NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

417 hedge funds and large institutions have $8.63B invested in Neurocrine Biosciences in 2020 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 188 increasing their positions, 109 reducing their positions, and 68 closing their positions.

Holders
417
Holders Change
–
Holders Change %
0%
% of All Funds
8.44%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.14%
New
70
Increased
188
Reduced
109
Closed
68
Calls
$40.5M
Puts
$136M
Net Calls
-$95.1M
Net Calls Change
-$101M

Top Buyers

1
CAM
1
Congress Asset Management
Massachusetts
$73.8M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$207M
3
HM
3
HealthCor Management
New York
$89.1M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$837M
5
Fiera Capital (Canada)
5
Fiera Capital (Canada)
Quebec, Canada
$27.5M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$411M
2
BlackRock
2
BlackRock
New York
$655M
3
PA
3
Perceptive Advisors
New York
$149M
4
Jennison Associates
4
Jennison Associates
New York
$0
5
Deutsche Bank
5
Deutsche Bank
Germany
$48.9M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$837M 8,703,746 +337,012 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$785M 8,161,533 -317,806 -4%
BlackRock
3
BlackRock
New York
$655M 6,814,862 -691,828 -9%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$630M 6,548,393 +54,202 +0.8%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$618M 6,421,738 -257,855 -4%
Capital International Investors
6
Capital International Investors
California
$411M 4,275,476 -1,820,920 -30%
BG
7
Bellevue Group
Switzerland
$317M 3,297,451 +86,551 +3%
State Street
8
State Street
Massachusetts
$219M 2,277,389 -10,651 -0.5%
Renaissance Technologies
9
Renaissance Technologies
New York
$207M 2,149,464 +664,700 +45%
Invesco
10
Invesco
Georgia
$167M 1,733,473 -219,836 -11%
PA
11
Perceptive Advisors
New York
$149M 1,548,715 -592,695 -28%
Franklin Resources
12
Franklin Resources
California
$147M 1,530,160 +77,878 +5%
RSCM
13
Rock Springs Capital Management
Maryland
$141M 1,465,500 +99,000 +7%
PAMU
14
Pictet Asset Management (UK)
United Kingdom
$128M 1,330,523 +23,769 +2%
O
15
OrbiMed
New York
$125M 1,301,715 +115,800 +10%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$107M 1,112,707 +140,008 +14%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$102M 1,066,602 -42,408 -4%
Macquarie Group
18
Macquarie Group
Australia
$91.4M 950,141 +37,532 +4%
HM
19
HealthCor Management
New York
$89.1M 927,070 +571,300 +161%
Goldman Sachs
20
Goldman Sachs
New York
$85.5M 889,171 -55,498 -6%
First Trust Advisors
21
First Trust Advisors
Illinois
$81.2M 844,289 -12,747 -1%
DCP
22
DSM Capital Partners
Florida
$80.5M 836,766 -28,848 -3%
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$74.8M 765,478 +43,721 +6%
CAM
24
Congress Asset Management
Massachusetts
$73.8M 767,650 +767,650 New
Norges Bank
25
Norges Bank
Norway
$71.1M 739,351 -13,200 -2%
1
2 3 4 5